Q3FY19 result highlights
Rallis reported revenue growth in line with our expectation, however EBITDA was below our estimates.
Key positives: New product launches in the domestic market, higher realisations in the export market
Key negatives: Decline in Gross margins
Impact on financials: Cut EPS by 14.6%/12.5% for FY19E/20E respectively to factor in decline in gross margins. We introduce FY21e EPS of Rs13.1/sh.
Our view
Rallis reported healthy revenue growth in Q3FY19 despite weak rabi season led by market share gains in the domestic pesticides business and improved realisations in the export business. Despite healthy revenue growth, sharp increase in raw material costs impacted profitability. Going forward we expect the revenue growth momentum to continue with increasing share of speciality products, easing of credit norms to dealers ,supported by Rallis’s strong distribution network. Moreover, Rallis’s plans to invest Rs2.7bn(Rs1bn in phase 1) to backward integrate for 2-3 key raw molecules which it imports from China augurs well on account of supply-side constraints from China. In the long run we believe, potential success in new formulations, commercialisation of new products under contract manufacturing and scale up in the seeds business are key triggers for the stock. Moreover introduction of several measures focused on improving farm income (MSP hikes) and normal monsoons in key geographies augurs well for Rallis. We maintain Outperformer on the stock with revised target price of Rs209 which is at 21x FY21E EPS of Rs13.1/sh. Maintain Outperformer
Rallis India Limited is engaged in the business of manufacture and marketing of Agri Inputs. The Company has its manufacturing facilities in India and sells both in India and across the globe. The Company's segments include Agri-Inputs and Others. The Agri-Inputs segment consists of Pesticides, Plant Growth Nutrients (PGN) and Seeds. The Other segment consists of Polymer. The Company's Non-Pesticide Portfolio includes Agri Services. Its Agri Services portfolio consists of the organic manure product GeoGreen, Samrudh Krishi (SK) initiative, MoPu (More Pulses) initiative and agri implements. The Company's products for crop protection, such as fungicides, including Contaf, Contaf Plus, Master and Fujione; weedicides, including Fateh, Tata Metri, Tata Panida, and insecticides, including Tata Mida, Reeva, Asataf and Manik. The Company also offers various category of products, including hybrid maize, hybrid paddy, hybrid pearl millet, mustard and wheat.
IDFC Securities Ltd., a subsidiary of the Infrastructure Development Finance Company (IDFC) wherein the Government of India holds a 20% interest, is India's leading equities broker catering to most of the prominent financial institutions, both foreign and domestic investing in Indian equities. A research team of experienced and dedicated experts ensures the flow of critically investigated stock ideas and portfolio strategies for our clients. Our coverage spans across various growth sectors such as agriculture, automobiles, Consumer Goods, Technology, Healthcare, Infrastructure, Media, Power, Real Estate, Telecom, Capital Goods, Logistics, Cement amongst other sectors. Our clients value us for our strong research-led investment ideas, superior client servicing track record and exceptional execution skills.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.